-
公开(公告)号:US07652015B2
公开(公告)日:2010-01-26
申请号:US12088526
申请日:2006-10-25
申请人: Jolie Anne Bastian , Jesus Andres Blas de Blas , Alfonso De Dios , Kevin John Hudziak , Tiechao Li , Beatriz López De Uralde-Garmendia , Mary Margaret Mader , Michael Ray Myers , Mark Andrew Pobanz , Chuan Shih , Boyu Zhong
发明人: Jolie Anne Bastian , Jesus Andres Blas de Blas , Alfonso De Dios , Kevin John Hudziak , Tiechao Li , Beatriz López De Uralde-Garmendia , Mary Margaret Mader , Michael Ray Myers , Mark Andrew Pobanz , Chuan Shih , Boyu Zhong
IPC分类号: A61K31/4439 , A61K31/454 , C07D401/12 , C07D401/14 , C07D409/14
CPC分类号: C07D401/12 , C07D401/14
摘要: The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供式(I)的激酶抑制剂。 其中R1,R2,X和Z如本文所述,或其药学上可接受的盐。
-
2.
公开(公告)号:US07582638B2
公开(公告)日:2009-09-01
申请号:US12089420
申请日:2006-10-23
申请人: Alfonso De Dios , Cristina Garcia-Paredes , Beatriz López de Uralde Garmendia , Mary Margaret Mader , Mark Andrew Pobanz , Chuan Shih , Boyu Zhong
发明人: Alfonso De Dios , Cristina Garcia-Paredes , Beatriz López de Uralde Garmendia , Mary Margaret Mader , Mark Andrew Pobanz , Chuan Shih , Boyu Zhong
IPC分类号: A61K31/4725 , A61K31/496 , C07D403/141
CPC分类号: C07D403/12 , C07D403/14
摘要: The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供其中R1,R2和X如本文所述的式(I)的激酶抑制剂或其药学上可接受的盐。
-
公开(公告)号:US07081481B2
公开(公告)日:2006-07-25
申请号:US10276532
申请日:2001-05-24
IPC分类号: A61K31/197 , C07C229/28
CPC分类号: C07C271/30 , C07B2200/07 , C07C229/46 , C07C271/22 , C07C271/24 , C07C271/28 , C07C275/18 , C07C275/24 , C07C275/28 , C07C311/19 , C07C335/16 , C07C2601/02 , C07C2601/14
摘要: Compounds of the formula (I) in which: R1 is (CH2)nY; n is 1 or 2; Y is NHSO2R2 or X1—W—X2—R3; X1 is O or NH; W is C═O, C═S, C═NH, or SO2; X2 is O or NH, provided that X1 and X2 are not both O; R2 is C1-10 alkyl; C2-10 alkenyl; C2-10 alkynyl; aryl; aryl-C1-10 alkyl; aryl-C2-10 alkenyl; aryl-C2-10alkynyl; C3-8 cycloalkyl or C3-8-cycloalkyl-C1-10 alkyl; and R3 is hydrogen, C1-10alkyl; C2-10 alkenyl; C2-10 alkynyl; aryl; aryl-C1-10 alkyl; aryl-C2-10 alkenyl; aryl-C2-10 alkynyl; C3-8 cycloalkyl; or C3-8-cycloalkyl-C1-10 alkyl; or a salt or ester thereof, modulate metabotropic glutamate receptor function and are useful in treating disorders of the central nervous system.
摘要翻译: 式(I)的化合物,其中:R 1是(CH 2)n Y; n为1或2; Y是NHSO 2 R 2或X 1 -WX 2 - 3 - 3 ; X 1是O或NH; W是C-O,C-S,C-NH或SO 2。 X 2是O或NH,条件是X 1和X 2都不是O; R 2是C 1-10烷基; C 2-10链烯基; C 2-10炔基; 芳基; 芳基-C 1-10烷基; 芳基-C 2-10链烯基; 芳基-C 2-10炔基; C 3-8环烷基或C 3-8 - 环烷基-C 1-10烷基; R 3是氢,C 1-10烷基; C 2-10链烯基; C 2-10炔基; 芳基; 芳基-C 1-10烷基; 芳基-C 2-10链烯基; 芳基-C 2-10炔基; C 3-8环烷基; 或C 3-8 - 环烷基-C 1-10烷基; 或其盐或酯调节代谢型谷氨酸受体功能,并且可用于治疗中枢神经系统疾病。
-
-